Overview

Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination

Status:
Active, not recruiting
Trial end date:
2022-02-15
Target enrollment:
0
Participant gender:
All
Summary
Investigating cytotoxicity of yellow fever specific CD8 T cells following YF-17D vaccination and the following licensing of these epitope-specific CD8 T cells
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Aarhus
Collaborator:
Martin Tolstrup
Treatments:
Vaccines
Criteria
Inclusion Criteria:

- Age between 18 to 60 years

- Informed consent given

Exclusion Criteria:

- Fever (orally >37,5 C) on day of vaccination

- Immunosuppressants

- Pregnant or breast feeding

- Severe immunodeficiency

- Known thymus dysfunction

- Allergy against egg

- Known haemophilia

- Previous severe reaction to vaccine

- Not willing to use anticonceptives 4 weeks after vaccination